regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - imunitný séra a imunoglobulíny, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - imunitný séra a imunoglobulíny, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. pozri časti 4. 4 a 5.
ciprinol
krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
medociprin 250 mg
medochemie ltd., cyprus - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
medociprin 500 mg
medochemie ltd., cyprus - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciplox 250
cipla europe nv, belgicko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciplox 500
cipla europe nv, belgicko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciphin 500
zentiva a.s., slovensko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciprofloxacín sandoz 500 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)